- Home
- ZYME vs CARS Comparison
ZYME vs CARS Comparison
Compare ZYME & CARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- CARS
- Stock Information
- Founded
- ZYME 2003
- CARS 1998
- Country
- ZYME United States
- CARS United States
- Employees
- ZYME N/A
- CARS N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- CARS Motor Vehicles
- Sector
- ZYME Health Care
- CARS Consumer Discretionary
- Exchange
- ZYME Nasdaq
- CARS Nasdaq
- Market Cap
- ZYME 846.1M
- CARS 723.4M
- IPO Year
- ZYME 2017
- CARS 2017
- Fundamental
- Price
- ZYME $11.43
- CARS $10.25
- Analyst Decision
- ZYME Buy
- CARS Buy
- Analyst Count
- ZYME 7
- CARS 5
- Target Price
- ZYME $19.50
- CARS $18.30
- AVG Volume (30 Days)
- ZYME 449.0K
- CARS 832.1K
- Earning Date
- ZYME 05-08-2025
- CARS 05-08-2025
- Dividend Yield
- ZYME N/A
- CARS N/A
- EPS Growth
- ZYME N/A
- CARS N/A
- EPS
- ZYME N/A
- CARS 0.69
- Revenue
- ZYME $93,384,000.00
- CARS $718,000,000.00
- Revenue This Year
- ZYME $34.23
- CARS $3.77
- Revenue Next Year
- ZYME $68.78
- CARS $3.14
- P/E Ratio
- ZYME N/A
- CARS $14.89
- Revenue Growth
- ZYME 85.05
- CARS 2.24
- 52 Week Low
- ZYME $8.21
- CARS $9.56
- 52 Week High
- ZYME $17.70
- CARS $21.24
- Technical
- Relative Strength Index (RSI)
- ZYME 45.92
- CARS 39.99
- Support Level
- ZYME $11.46
- CARS $9.98
- Resistance Level
- ZYME $11.81
- CARS $10.38
- Average True Range (ATR)
- ZYME 0.59
- CARS 0.35
- MACD
- ZYME -0.05
- CARS -0.03
- Stochastic Oscillator
- ZYME 27.62
- CARS 17.10
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About CARS Cars.com Inc.
Cars.com Inc is an online destination for buying and selling new and used vehicles. It is an audience-driven technology company empowering the automotive industry. The company brands include Dealer Inspire, DealerRater, FUEL, Accu-Trade, PickupTrucks.com, CreditIQ, and NewCars.com., websites directed towards different consumer segments.